MetaADEDB 2.0 @ LMMD
Methoxsalen
(QXKHYNVANLEOEG-UHFFFAOYSA-N)
Structure
SMILES
COc1c2oc(=O)ccc2cc2c1occ2
Type(s)
Approved
ATC code(s)
D05AD02; D05BA02
Molecular Formula:
C12H8O4
Molecular Weight:
216.190
Log P:
2.5478
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
52.58
CAS Number(s):
298-81-7
Synonym(s)
1.
Methoxsalen
2.
8-Methoxypsoralen
3.
Ammoidin
4.
Xanthotoxin
5.
8-MOP
6.
Deltasoralen
7.
Dermox
8.
Geroxalen
9.
Meladinina
10.
Meladinine
11.
Meloxine
12.
Methoxa-Dome
13.
Méladinine
14.
Oxsoralen
15.
Oxsoralen-Ultra
16.
Puvalen
17.
Ultramop
18.
8 MOP
19.
8 Methoxypsoralen
20.
8MOP
21.
Methoxa Dome
22.
Oxsoralen Ultra
External Link(s)
MeSHD008730
PubChem Compound4114
BindingDB50041234
ChEBI18358
CHEMBLCHEMBL416
DrugBankDB00553
DrugCentral30
KEGGcpd:C01864
dr:D00139
Therapeutic Target DatabaseD08SKH
ZINC2548959
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product use in unapproved indicationFAERS: 48US FAERS
2ChillsFAERS: 8US FAERS
3FatigueFAERS: 7US FAERS
4PruritusFAERS: 6
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
5Pulmonary EmbolismFAERS: 6US FAERS
6VomitingFAERS: 6US FAERS
7Abdominal PainFAERS: 58784281CTD
US FAERS
8Disease ProgressionFAERS: 5US FAERS
9Drug ineffectiveFAERS: 5US FAERS
10HypotensionFAERS: 5SIDER
US FAERS
11NauseaFAERS: 58784281CTD
SIDER
US FAERS
12Drug effect incompleteFAERS: 4US FAERS
13InfectionFAERS: 4SIDER
US FAERS
14Injection site bruisingFAERS: 4US FAERS
15SepsisFAERS: 4US FAERS
16CataractFAERS: 3US FAERS
17Disease recurrenceFAERS: 3US FAERS
18DizzinessFAERS: 3SIDER
US FAERS
19HeadacheFAERS: 38784281CTD
SIDER
US FAERS
20Mycosis FungoidesFAERS: 316259964CTD
US FAERS
21Peripheral swellingFAERS: 3US FAERS
22PneumoniaFAERS: 3US FAERS
23ThrombosisFAERS: 3US FAERS
24White blood cell count decreasedFAERS: 3US FAERS
25AgitationFAERS: 2US FAERS
26Air EmbolismFAERS: 2US FAERS
27AlopeciaFAERS: 2US FAERS
28AngioedemaFAERS: 2US FAERS
29Cerebrovascular accidentFAERS: 2US FAERS
30Chemical burn of skinFAERS: 2US FAERS
31Chest PainFAERS: 2US FAERS
32Device related infectionFAERS: 2SIDER
US FAERS
33Lip swellingFAERS: 2US FAERS
34MalaiseFAERS: 2SIDER
US FAERS
35Respiratory distressFAERS: 2US FAERS
36Suture ruptureFAERS: 2US FAERS
37Temperature intoleranceFAERS: 2US FAERS
38Vascular Access ComplicationFAERS: 2US FAERS
39WheezingFAERS: 2US FAERS
40Abdominal discomfortFAERS: 1US FAERS
41Adverse eventFAERS: 1US FAERS
42AnxietyFAERS: 1US FAERS
43ArthralgiaFAERS: 1US FAERS
44AstheniaFAERS: 1US FAERS
45Atrial tachycardiaFAERS: 1US FAERS
46BK virus infectionFAERS: 1US FAERS
47Back PainFAERS: 1US FAERS
48Blood iron decreasedFAERS: 1US FAERS
49Blood triglycerides increasedFAERS: 1US FAERS
50Cardiac ArrestFAERS: 1US FAERS
51Cataract operationFAERS: 1US FAERS
52Catheter site related reactionFAERS: 1US FAERS
53Cerebral InfarctionFAERS: 1US FAERS
54Chest discomfortFAERS: 1US FAERS
55Chronic respiratory failureFAERS: 1US FAERS
56Deep Vein ThrombosisFAERS: 1US FAERS
57Device alarm issueFAERS: 1US FAERS
58Device malfunctionFAERS: 1US FAERS
59Drug ineffective for unapproved indicationFAERS: 1US FAERS
60DysgeusiaFAERS: 1SIDER
US FAERS
61EpistaxisFAERS: 1US FAERS
62ErythemaFAERS: 1
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
63Feeling ColdFAERS: 1US FAERS
64Feeling abnormalFAERS: 1SIDER
US FAERS
65FlushingFAERS: 1US FAERS
66Head discomfortFAERS: 1US FAERS
67Histiocytosis haematophagicFAERS: 1US FAERS
68HypersensitivityFAERS: 1SIDER
US FAERS
69HypoxiaFAERS: 1US FAERS
70Incorrect drug administration durationFAERS: 1US FAERS
71MetamorphopsiaFAERS: 1US FAERS
72Molluscum ContagiosumFAERS: 1US FAERS
73Occupational exposure to productFAERS: 1US FAERS
74Ocular ToxicityFAERS: 1US FAERS
75PainFAERS: 1US FAERS
76PallorFAERS: 1US FAERS
77PhotophobiaFAERS: 1US FAERS
78PneumonitisFAERS: 1US FAERS
79Post procedural complicationFAERS: 1US FAERS
80Product substitution issueFAERS: 1US FAERS
81Protein total increasedFAERS: 1US FAERS
82Respiratory FailureFAERS: 1US FAERS
83Retinal toxicityFAERS: 1US FAERS
84SclerodermaFAERS: 1US FAERS
85Skin irritationFAERS: 1US FAERS
86Skin squamous cell carcinoma metastaticFAERS: 1US FAERS
87SomnolenceFAERS: 1US FAERS
88Sudden Cardiac DeathFAERS: 1US FAERS
89Supraventricular tachycardiaFAERS: 1US FAERS
90SwellingFAERS: 1US FAERS
91SyncopeFAERS: 1US FAERS
92TachycardiaFAERS: 1US FAERS
93ThrombocytopeniaFAERS: 1US FAERS
94Thrombosis in deviceFAERS: 1US FAERS
95Tonic clonic movementsFAERS: 1US FAERS
96Transfusion ReactionFAERS: 1US FAERS
97Transmission of an infectious agent via productFAERS: 1US FAERS
98Transmission of drug via semenFAERS: 1US FAERS
99Unevaluable eventFAERS: 1US FAERS
100Venous occlusionFAERS: 1US FAERS
101Vessel puncture site bruiseFAERS: 1US FAERS
102Visual ImpairmentFAERS: 1US FAERS
103Wrong technique in device usage processFAERS: 1US FAERS
104Wrong technique in product usage processFAERS: 1US FAERS
105Catheter infectionSIDER
106Chemical and Drug Induced Liver Injury3105541
22173200
28552422		CTD
107Cholestasis28552422CTD
108Cramps of lower extremitiesSIDER
109Dermatitis acneiformSIDER
110DermatitisSIDER
111DiscomfortSIDER
112Dry skinSIDER
113DyspepsiaSIDER
114Eczema16259964CTD
115FolliculitisSIDER
116Hepatomegaly28552422CTD
117InflammationSIDER
118Kidney Diseases2344991CTD
119LeukodermaSIDER
120Liver Failure, Acute8308218CTD
121Lung Neoplasms15893417CTD
122Lupus ErythematosusSIDER
123Lymphoma, T-Cell, Cutaneous17003103CTD
124Mechanical urticariaCanada Vigilance: 1Canada Vigilance
125Migraine Disorders16869874CTD
126MiliariaSIDER
127NervousnessSIDER
128Olfaction Disorders12925193
16869874		CTD
129Pain of skinSIDER
130Psoriasis

View details

8308218
8784281
12925193
14571091
16259964
17003103
28552422
 		CTD
131Purpura7232190CTD
132RednessSIDER
133Sleep Initiation and Maintenance Disorders14571091CTD
134Solar lentigoSIDER
135SunburnSIDER
136TensionSIDER
137Tinea Capitis14571091CTD
138UrticariaSIDER
139VertigoSIDER
140Vestibular Diseases18990727CTD
141Vitiligo16259964
28552422		CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.